A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection: the Phase 3 ION-4 study
Publication
, Journal Article
Rockstroh, J; Cooper, C; Naggie, S; Saag, M; Yang, J; Stamm, L; Pang, P; McHutchison, J; Dieterich, D; Sulkowski, M
Published in: JOURNAL OF VIRAL HEPATITIS
September 1, 2015
Duke Scholars
Published In
JOURNAL OF VIRAL HEPATITIS
EISSN
1365-2893
ISSN
1352-0504
Publication Date
September 1, 2015
Volume
22
Start / End Page
24 / 24
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Gastroenterology & Hepatology
- 3207 Medical microbiology
- 3202 Clinical sciences
- 1108 Medical Microbiology
- 1103 Clinical Sciences
- 0605 Microbiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rockstroh, J., Cooper, C., Naggie, S., Saag, M., Yang, J., Stamm, L., … Sulkowski, M. (2015). A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection: the Phase 3 ION-4 study. JOURNAL OF VIRAL HEPATITIS, 22, 24–24.
Rockstroh, J., C. Cooper, S. Naggie, M. Saag, J. Yang, L. Stamm, P. Pang, J. McHutchison, D. Dieterich, and M. Sulkowski. “A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection: the Phase 3 ION-4 study.” JOURNAL OF VIRAL HEPATITIS 22 (September 1, 2015): 24–24.
Rockstroh J, Cooper C, Naggie S, Saag M, Yang J, Stamm L, et al. A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection: the Phase 3 ION-4 study. JOURNAL OF VIRAL HEPATITIS. 2015 Sep 1;22:24–24.
Rockstroh, J., et al. “A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection: the Phase 3 ION-4 study.” JOURNAL OF VIRAL HEPATITIS, vol. 22, WILEY-BLACKWELL, Sept. 2015, pp. 24–24.
Rockstroh J, Cooper C, Naggie S, Saag M, Yang J, Stamm L, Pang P, McHutchison J, Dieterich D, Sulkowski M. A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection: the Phase 3 ION-4 study. JOURNAL OF VIRAL HEPATITIS. WILEY-BLACKWELL; 2015 Sep 1;22:24–24.
Published In
JOURNAL OF VIRAL HEPATITIS
EISSN
1365-2893
ISSN
1352-0504
Publication Date
September 1, 2015
Volume
22
Start / End Page
24 / 24
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Gastroenterology & Hepatology
- 3207 Medical microbiology
- 3202 Clinical sciences
- 1108 Medical Microbiology
- 1103 Clinical Sciences
- 0605 Microbiology